Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704367 | SCV000528832 | likely benign | not provided | 2020-10-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000465242 | SCV000556672 | likely benign | Tuberous sclerosis 2 | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001025075 | SCV001187197 | likely benign | Hereditary cancer-predisposing syndrome | 2019-01-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000465242 | SCV002041239 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001025075 | SCV002534081 | likely benign | Hereditary cancer-predisposing syndrome | 2021-12-26 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002488944 | SCV002804109 | likely benign | Lymphangiomyomatosis; Isolated focal cortical dysplasia type II; Tuberous sclerosis 2 | 2022-03-30 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004000463 | SCV004816991 | likely benign | Tuberous sclerosis syndrome | 2024-01-03 | criteria provided, single submitter | clinical testing |